β¨ Notices and Consents
NEW ZEALAND GAZETTE, No. 69 β 4 AUGUST 2016
Notice of Variation of a Scheduled International Air Service Licence
Further to a notice published in the New Zealand Gazette, 16 June 2016, Issue No. 54, Notice No. 2016-go3457, and pursuant to section 87J(6) of the Civil Aviation Act 1990, sections 28, 29 and 41 of the State Sector Act 1988, a delegation from the Minister of Transport dated 29 October 2013, and a sub-delegation from the Chief Executive of the Ministry of Transport dated 3 November 2013, I give notice that, having received an application from Air New Zealand Limited, the Minister of Transport has varied the Scheduled International Air Service Licence held by that airline to provide for code-share services to Colombia.
The variation took effect on 11 July 2016.
Signed at Wellington this 27th day of July 2016.
NICK BROWN, General Manager, Aviation and Maritime, Ministry of Transport.
2016-go4426
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Granisetron 3mg/3mL
Active Ingredient:
Granisetron hydrochloride 1.12mg/mL equivalent to granisetron 1mg/mL
Dosage Form:
Solution for injection
New Zealand Sponsor:
Deva Holdings NZ Limited
Manufacturer:
Deva Holding AS, Kartepe, Turkey
Product:
Ipca-Citalopram
Active Ingredient:
Citalopram hydrobromide 24.99mg equivalent to citalopram 20mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Actavis New Zealand Limited
Manufacturer:
Ipca Laboratories Limited, Silvassa, India
Product:
Ipca-Losartan
Active Ingredient:
Losartan potassium 12.5mg
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Actavis New Zealand Limited
Manufacturer:
Ipca Laboratories Limited, Silvassa, India
Product:
Lumexia
Active Ingredient:
Methyl aminolevulinate hydrochloride 200mg/g equivalent to methyl aminolevulinate 160mg/g
Dosage Form:
Topical cream
New Zealand Sponsor:
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer:
Penn Pharmaceutical Services Limited, Tredegar, United Kingdom
Product:
Sodium Chloride for Injection 0.9%
Active Ingredient:
Sodium chloride 0.9% w/v
Dosage Form:
Solution for injection
New Zealand Sponsor:
InterPharma (NZ) Limited
Manufacturer:
Amanta Healthcare Limited, Hariyala, India
Product:
Water for Injections BP
Active Ingredient:
Water for injection 100% v/v
Dosage Form:
Solution for injection
New Zealand Sponsor:
InterPharma (NZ) Limited
Manufacturer:
Amanta Healthcare Limited, Hariyala, India
Dated this 29th day of July 2016.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2016-go4456
46
Next Page →
β¨ LLM interpretation of page content
π Variation of Scheduled International Air Service Licence
π Transport & Communications27 July 2016
Air Service Licence, Variation, Air New Zealand, Code-share, Colombia
- NICK BROWN, General Manager, Aviation and Maritime, Ministry of Transport
π₯ Consent to Distribution of New Medicines
π₯ Health & Social Welfare29 July 2016
Medicines, Consent, Distribution, Granisetron, Ipca-Citalopram, Ipca-Losartan, Lumexia, Sodium Chloride, Water for Injections
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
NZ Gazette 2016, No 69